6JPMA.Pharmaceutical administration and regulations in Japan2012[EB/OL].(2012-03)[2012-09-16].http://www.jpma.or.jp/english/parj/1003.html.
7Hoppu K,Anabwani G,Garcia-Bournissen F,et al.The status of paediatric medicinesinitiatives around the world:what has happened and what has not?[J].Eur J Clin Pharmacol,2012,68(1):1.
8Hidefumi N,Masahiro O.Facilitation of paediatric research in Japan[M].Tokyo:Karger Publishers,2010:1522.
9Beckloff Associates.Pediatric exclusivity and drug development requirements in the overall pediatric population[EB/OL].(2009-08-05)[2012-09-16].http://cardinalhealth.com/beckloff/documents/pdf/PEDIATRIC%20EXCLUSIVITY090209.
10Washington Reports.Federal court invalidates FDA’s‘pediatric rule’on drug safety tests[EB/OL].(2003-0101)[2013-04-19].http://www.cancernetwork.com/display/article/10165/104753.
